The JNM Podcast is back in 2025! Join Ken Herrmann, MD, and co-moderator Frank Bengel, MD, for an episode on cardiovascular perfusion imaging. In the U.S., SPECT imaging makes up five to six million studies per year. But PET studies make up just 2.2 million, and only 7%, or 150,000 of those, are cardiac PET imaging. But that may be about to change. The FDA has recently approved Flurpiridaz F-18, which may make cardiac imaging more accessible to patients across the country. Here to discuss the utility of the F-18 label and the future of myocardial perfusion imaging are Jamshid Maddahi, MD, FACC, FASNC, and Sharmila Dorbala, MD, MPH.

Thanks to GE Healthcare for sponsoring this episode! https://www.gehealthcare.com/products/molecular-imaging-agents/flyrcado